On Friday May 1 Gilead’s investigational antiviral drug Remdesivir received emergency use authorization for the treatment of COVID-19. Gilead’s CEO Dan O’day indicated “We intend to get that to patients in the early part of this next week,” while on CBS’ “Face of the Nation”. He went on to state that Gilead has donated 1.5...